Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saccharomyces Boulardii for Prevention of Antibiotic-associated Diarrhoea
NCT01143272Phase 3Terminated
- Sponsor
- Bernhard Nocht Institute for Tropical Medicine
- Start
- Jun 2010
- Primary completion
- Oct 2012
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of saccharomyces boulardii in antibiotic-associated diarrhea (AAD), Clostridium difficile infection (CDI), sponsored by Bernhard Nocht Institute for Tropical Medicine. Started Jun 2010; status: terminated.
02
Drugs
saccharomyces boulardii
03
Conditions
antibiotic-associated diarrhea (AAD)Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT01143272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01143272.